CSTL - Castle Biosciences GAAP EPS of $0.15 beats by $0.68, revenue of $86.19M beats by $14.78M
2025-08-04 16:16:47 ET
More on Castle Biosciences
- Castle Biosciences Q2 2025 Earnings Preview
- Castle Biosciences, Revolution Medicines get FDA breakthrough statuses
- Seeking Alpha’s Quant Rating on Castle Biosciences
- Historical earnings data for Castle Biosciences
- Financial information for Castle Biosciences